77 engineering-computation-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"UCL" positions at City of Hope
Sort by
Refine Your Search
-
. Instructor activities include but not limited to moderating weekly group discussions; planning and supervising group activity; ensuring students complete all program requirements for example course assignment
-
-paced research in cutting-edge technology, immunotherapeutic programs, and a commitment to delivering innovative solutions to critical illnesses. For more information on T Cell Therapeutics research
-
in biological sciences, engineering, or related field (Masters or PhD preferred). · Minimum of 5 years of experience working with human T-cells, primary human cells, immune systems or similar
-
a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer
-
About the lab We are a newly established computational research group at the Translational Genomics Research Institute developing and applying pangenome methods to study genome variation and
-
, immunohistochemistry, or genomic technologies. Demonstrated productivity through peer-reviewed publications. Preferred qualifications: Strong research background in genetic engineered mouse modeling, molecular and
-
) is a member of the nursing research team led by a nurse scientist. You will lead study activities through delivery of technology and telehealth-driven interventions to support patient symptom
-
. CAR NK or CAR T cell engineering and application. Use of conditional knockout mice, tumor models, or MCMV infection systems. CRISPR screening and CRISPR-based gene editing. Epigenetic regulation of gene
-
records and the training program. · Coordinate and conduct Internal audits, follow up and write reports for submission to QA management. Track and follow up on audit commitments for timely
-
motivated Research Associate II (RA II) to join our team. The Caligiuri lab focuses on NK cell biology, cancer immunotherapy through engineered CAR T and/or CAR NK cells, oncolytic virotherapy, antibody